NATCO Pharma Limited (BOM: 524816)

NATCO Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	15,621	704	1,319	1,111	258	198
Short-Term Investments	9,013	13,208	6,612	6,488	7,919	8,827
Cash & Short-Term Investments	24,634	13,912	7,931	7,599	8,177	9,025
Cash Growth	102.65%	75.41%	4.37%	-7.07%	-9.40%	-14.67%
Accounts Receivable	14,357	11,889	8,561	6,206	4,129	5,513
Other Receivables	-	706	351	545	721	736
Receivables	14,458	12,685	9,014	6,855	4,981	6,333
Inventory	7,746	7,917	8,089	8,620	9,104	6,987
Prepaid Expenses	-	289	283	326	226	180
Other Current Assets	3,177	5,432	4,686	1,467	960	731
Total Current Assets	50,015	40,235	30,003	24,867	23,448	23,256
Property, Plant & Equipment	25,382	24,350	23,034	23,084	22,372	20,936
Long-Term Investments	1,686	959	873	1,044	1,519	836
Goodwill	562	560	552	507	-	-
Other Intangible Assets	1,814	1,371	1,326	822	94	88
Long-Term Deferred Tax Assets	385	194	-	-	-	-
Other Long-Term Assets	2,603	1,394	786	767	472	601
Total Assets	82,447	69,063	56,574	51,091	47,919	45,878
Accounts Payable	3,144	2,355	2,638	1,618	1,462	2,554
Accrued Expenses	-	843	691	569	480	446
Short-Term Debt	2,010	3,781	1,744	4,205	2,821	3,277
Current Portion of Leases	23	27	6	35	9	8
Current Income Taxes Payable	1,203	323	101	9	13	85
Other Current Liabilities	3,707	2,399	1,651	668	471	483
Total Current Liabilities	10,087	9,728	6,831	7,104	5,256	6,853
Long-Term Leases	51	53	11	80	9	9
Long-Term Deferred Tax Liabilities	2	2	124	301	413	259
Other Long-Term Liabilities	739	483	402	396	397	346
Total Liabilities	10,879	10,532	7,836	8,455	6,685	8,031
Common Stock	358	358	365	365	365	364
Additional Paid-In Capital	-	12,019	14,065	14,078	13,915	13,729
Retained Earnings	-	45,252	33,518	27,261	26,277	22,986
Comprehensive Income & Other	71,141	902	790	932	659	656
Total Common Equity	71,499	58,531	48,738	42,636	41,216	37,735
Minority Interest	69	-	-	-	18	112
Shareholders' Equity	71,568	58,531	48,738	42,636	41,234	37,847
Total Liabilities & Equity	82,447	69,063	56,574	51,091	47,919	45,878
Total Debt	2,084	3,861	1,761	4,320	2,839	3,294
Net Cash (Debt)	22,550	10,051	6,170	3,279	5,338	5,731
Net Cash Growth	132.93%	62.90%	88.17%	-38.57%	-6.86%	-14.63%
Net Cash Per Share	125.90	56.00	33.80	17.98	29.25	31.41
Filing Date Shares Outstanding	179.13	179.11	182.47	182.52	182.34	182.07
Total Common Shares Outstanding	179.13	179.11	182.47	182.52	182.34	182.07
Working Capital	39,928	30,507	23,172	17,763	18,192	16,403
Book Value Per Share	399.14	326.79	267.10	233.60	226.04	207.26
Tangible Book Value	69,123	56,600	46,860	41,307	41,122	37,647
Tangible Book Value Per Share	385.88	316.01	256.81	226.31	225.53	206.77
Land	-	3,692	2,855	2,641	2,476	2,487
Buildings	-	11,080	10,593	9,734	8,966	6,225
Machinery	-	18,340	17,616	16,798	15,013	12,247
Construction In Progress	-	1,373	643	1,295	2,234	5,180

Source: S&P Capital IQ. Standard template. Financial Sources.